Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Feagan

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|December 22, 1999
Review article: economic issues in Crohn's disease--assessing the effects of new treatments on health-related quality of lifeB G Feagan
Inflammatory Bowel Diseases|January 4, 2013
Cyclosporine has no proven role as a therapy for Crohn's diseaseB G Feagan
Inflammatory Bowel Diseases|August 1, 1998
Methotrexate treatment for Crohn's diseaseB G Feagan
Acta Gastro-Enterologica Belgica|July 28, 2001
Safety of biologics: current issues and future concernsB G Feagan
Gastroenterology|June 1, 1996
Oral budesonide therapy for ulcerative colitis: a topical taleB G Feagan
The Journal of Pediatrics|January 1, 1997
Methotrexate therapy for chronic sarcoidosis: is the therapeutic index acceptable?B G Feagan
Acta Gastro-Enterologica Belgica|July 28, 2001
Standard immunosuppression in IBD: current practiceB G Feagan
Pharmacotherapy|July 12, 2001
A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing LevofloxacinB G Feagan
The European Journal of Surgery = Acta Chirurgica|February 24, 1999
Aminosalicylates for active disease and in the maintenance of remission in Crohn's diseaseB G Feagan
Inflammatory Bowel Diseases|January 4, 2013
Methotrexate for ulcerative colitis-discouraging newsB G Feagan
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|December 22, 1999
Review article: economic issues in Crohn's disease--assessing the effects of new treatments on health-related quality of lifeB G Feagan
Inflammatory Bowel Diseases|January 4, 2013
Cyclosporine has no proven role as a therapy for Crohn's diseaseB G Feagan
Inflammatory Bowel Diseases|August 1, 1998
Methotrexate treatment for Crohn's diseaseB G Feagan
Acta Gastro-Enterologica Belgica|July 28, 2001
Safety of biologics: current issues and future concernsB G Feagan
Gastroenterology|June 1, 1996
Oral budesonide therapy for ulcerative colitis: a topical taleB G Feagan
The Journal of Pediatrics|January 1, 1997
Methotrexate therapy for chronic sarcoidosis: is the therapeutic index acceptable?B G Feagan
Acta Gastro-Enterologica Belgica|July 28, 2001
Standard immunosuppression in IBD: current practiceB G Feagan
Pharmacotherapy|July 12, 2001
A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing LevofloxacinB G Feagan
The European Journal of Surgery = Acta Chirurgica|February 24, 1999
Aminosalicylates for active disease and in the maintenance of remission in Crohn's diseaseB G Feagan
Inflammatory Bowel Diseases|January 4, 2013
Methotrexate for ulcerative colitis-discouraging newsB G Feagan
Pageof 8